Delcath to Present at the LD Micro 500 Virtual Investor Conference on Tuesday, September 1, 2020 at 3:00pm ET

NEXT STORY
Global Multiplexed Diagnostics Market Is Expected to Reach USD 38.30 Billion by 2027 : Fior Markets
PREV STORY
Generex Biotechnology Announces New Updated Agenda for Shareholder Conference Call on Wednesday August 26th, 2020 at 9:30 AM
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

New interim data demonstrate Sandoz proposed biosimilar rituximab has equivalent efficacy to reference product

ASSIST-FL trial demonstrates equivalent safety, efficacy, pharmacokinetics and pharmacodynamics of Sandoz proposed biosimilar rituximab ...

author_avatar
NASDAQ Market News

Pieris Pharmaceuticals to Present at Investor Conferences in November

BOSTON, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage ...

author_avatar
NASDAQ Market News

Newly Granted European Composition of Matter Patent Extends Exclusive Protection for VBL Therapeutics’ Lead Drug Candidate VB-111 until October 2033

TEL AVIV, Israel, Oct. 23, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (NASDAQ:VBLT), today announced ...

author_avatar
NASDAQ Market News